December 20, 2013 Mr. Frederic ChereauaTYR PHARMA INC • February 2nd, 2015 • Biological products, (no disgnostic substances)
AMENDED AND RESTATED RESEARCH FUNDING AND OPTION AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE a California nonprofit public benefit corporation and aTYR PHARMA, INC. a Delaware corporationResearch Funding and Option Agreement • February 2nd, 2015 • aTYR PHARMA INC • Biological products, (no disgnostic substances) • California
This Agreement is entered into this 19th day of January 2015 (the “Effective Date”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation located at 10550 North Torrey Pines Road, La Jolla, California 92037 (“TSRI”), and aTyr Pharma, Inc., a Delaware corporation located at 3545 John Hopkins Court, Suite #250, San Diego, CA 92121 (“Sponsor”), with respect to the facts set forth below.
AMENDED AND RESTATED RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • February 2nd, 2015 • aTYR PHARMA INC • Biological products, (no disgnostic substances) • California
This Amended and Restated Restricted Stock Purchase Agreement (this “Agreement”) is made and entered into as of December 18, 2014, by and between aTyr Pharma, Inc., a Delaware corporation (the “Company”), and John D. Mendlein (the “Purchaser”). Capitalized terms used but not otherwise defined herein will have the meanings ascribed to them in the Employment Agreement (as defined below).
